TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage change in liver fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in blood haematology values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in blood biochemistry values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hospitalizations for free bilirubin jaundice
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Difficult mask ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Grade 3/4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of dynamic sitting balance and trunk coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static sitting balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of diet advancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of approach and avoidance behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pulse rate measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety level measurements
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants with clinical remission (Induction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with clinical remission (Maintenance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ALT level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change in strain measured by speckle tracking echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: intra-pair differences in fetal growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strain values between singletons and twin pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: No emesis within 30 minutes of administration
Endpoint domain: Adverse events/effects
Primary endpoint: Differences in anthropometry-estimated fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thrombotic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Food Security
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Effect of the bean smoothie intervention on serum biomarkers of health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life of the patient
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients with PTSD
Endpoint domain: Mortality/survival
Primary endpoint: Quality of sleep during hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in confidence of audiological clinical management decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of gout flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of HI-E/RBC-TI responding subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of RC and ED readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Capabilities of Upper Extremity Test (CUE-T)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Skin Elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of Protein/creatinine ratio in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change of Albumin/creatinine ratio in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Target Attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to viral rebound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient's pain perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported orthostatic hypotension symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Differences in Breath Spectra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence and nature of treatment emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Health Status Survey (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postoperative Opioid Usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change From Baseline in MADRS Total Score to Week 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in MADRS Total Score to Week 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Experienced An Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in the number of emergency admissions for an avoidable reason
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Frequency of Diabetic Ketoacidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sleep Fragmentation Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Average Sleep Duration Per Night
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Degree of pain rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity Scoring of Atopic Dermatitis Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total transseptal puncture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of black holes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expanded disability status scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intensity of facial pigment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Methamphetamine use risk
Endpoint domain: Adverse events/effects
Primary endpoint: PrEP cascade progression
Endpoint domain: Resource use
Primary endpoint: Number of participants with interstitial pulmonary edema at hospital discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: maximal lateral excursion of mandible
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range of motion of shoulder abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: range of motion of neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Annualized Sexually Transmitted Infections (STIs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of subjects with clinically significant change from baseline in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with clinically significant change from baseline in electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Observed cosmetic difference of scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline in homeostasis model of assessment - insulin resistance (HOMA-IR) at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in total cholesterol at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in systolic blood pressure (SBP) at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent change from baseline in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Box and Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jamar hand-held dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in the number of colony forming units (CFUs) of microbial species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in MIC90 of selected colonized microbial species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in sleep disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in molecular potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving EASI 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Corneal stromal cell density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transradial technical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients converting to femoral artery access
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in corneal epithelial healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical rating scale for motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limbs' flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limbs' strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of MTX-101
Endpoint domain: Adverse events/effects
Primary endpoint: Progression to Nociplastic Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensory and motor duration of block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Inter-Recti Distance (IRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nurses' knowledge about high-alert medication administration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication safety climate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nurses' competency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nurses' practice during administration of high-alert medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors associated with administering high-alert medications
Endpoint domain: Adverse events/effects
Primary endpoint: CXCL2/8 content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield for a tissue diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission/complete remission with incomplete hematological recovery (CR/CRi*) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence and severity of treatment emergent adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Antibody titre after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tbit™ System sensitivity and specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD contrast alcohol vs. neutral inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD contrast covariance with craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brief Problem Monitor (BPM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intraoperative portocaval post-procedural gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants with Clinically Significant Change from Baseline in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children and adolescents with at least one dose of HPV vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Five Facet Mindfulness Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of 10-item Kessler Psychological Distress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of Overall Anxiety Severity and Impairment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of Overall Depression Severity and Impairment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of the Brief State Rumination Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of the momentary repetitive negative thinking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pregnancy distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Pain subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of patients presenting with acute opioid withdrawal, overdose, or requesting treatment for OUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of patients evaluated for MOUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of patients started on MOUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health and feeding related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GDM incidence rate
Endpoint domain: Mortality/survival
Primary endpoint: Adherence Retention rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of participants with abnormal findings in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the residual AHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic Intracranial Hemorrhage (sICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of new root surface caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Change in the finger total active range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in magnitude of reciprocal inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the PSQI score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Care gap closure (patients seen)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants reporting Treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting adverse events of special interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting adverse events leading to discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting solicited systemic AEs (IM dosing)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting solicited injection site AEs (IM dosing)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first MOGAD relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the amplitude of arm swing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the arm swing asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized Mini Mental Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: National Institutes of Health Stroke Scale Score-NIHSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Figure of 8 Walk Test (F8WT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Four Square Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning rate as indexed by change in the precision of visuomotor grip force adjustment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in blood-oxygen-level-dependent (BOLD) signal derived multi-voxel brain activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasmablast percentage of total B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralising antibody titre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Youth Risk and Behavior Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Service Assessment for Children and Adolescents
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Interactions with soldiers involving discussions about suicide risk
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in albumin, pre-albumin, and transferrin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Wound healing rate on 30, 60, 90 and 180 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Artificial dermis (AD) or split-thickness skin graft (STSG) take rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Physical Examination Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of new onset atrial fibrillation or conduction disturbances requiring pacemaker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Morphological evaluation of the pelvis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Hazardous Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Phosphatidylethanol (PEth) From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Optimal Antiretroviral (ART) Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of systemic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: hair shaft thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Target Lesion Primary Patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Blood biochemistry data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Spleen Volume Reduction 35 (SVR35)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Pain rating scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HARS anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perception of change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ability to mentalize and understand difficulties
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of participants achieving EASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with an IGA score of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with major complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in RSVP Reading performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hs-CRP (C reactive protein)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of different fungal infections isolated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Antifungal susceptibility pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Flow-mediated Arterial Dilatation diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of severe clinical or biological adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients attending scheduled lessons
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Flexibility of the scar tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the PaO2/FiO2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes